Zoledronate-Induced Large Vessel Vasculitis Diagnosed by PET/CT

Author:

Shchekochikhin Dmitry12ORCID,Vinogradskaya Olga1ORCID,Bublik Evgeniia1,Shmyreva Maria1,Koroba Gregory1,Farmanov Alexander13,Aslanidis Irakliy4,Pursanova Diana4ORCID,Manukova Veronica4,Zilov Alexey13,Zhivov Alexey1

Affiliation:

1. Department of Internal Medicine, Ilyinskaya Hospital, Novorizhskoe Hwy 9 Km, 143421 Moscow, Russia

2. Department of Cardiology, Sechenov University, 8-2 Trubetskaya Str., 119991 Moscow, Russia

3. Department of Endocrinology N1, Sechenov University, 8-2 Trubetskaya Str., 119991 Moscow, Russia

4. Bakulev National Medical Research Center of Cardiovascular Surgery, Roublyevskoe Shosse 135, 121552 Moscow, Russia

Abstract

Bisphosphonates remain a first-line treatment for osteoporosis. The most-widely used is zoledronate, which is well tolerated by most patients, but may rarely cause acute inflammatory reactions, which resemble those of large vessel vasculitis (LVV). We report a third case of LVV associated with zoledronic acid infusion, presenting with a 2-week history of fever up to 40 °C, flu-like symptoms, left jaw pain, myalgia, arthralgia, ankle stiffness in the morning, and intermittent claudication, diagnosed by the hybrid imaging modality 18F-FDG PET/CT with isolated lower extremity involvement and successfully treated with glucocorticoids.

Publisher

MDPI AG

Reference24 articles.

1. UK clinical guideline for the prevention and treatment of osteoporosis;Gregson;Arch. Osteoporos.,2022

2. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline;Eastell;J. Clin. Endocrinol. Metab.,2019

3. Giant cell arteritis with visual loss following zoledronic acid infusion;Metyas;Int. J. Rheum. Dis.,2014

4. Rare orbital manifestations and vasculitis, giant cell arteritis or side effects of zoledronic acid infusion?;Naderi;Arch. Gen. Intern. Med.,2019

5. Update on Rare Adverse Events from Osteoporosis Therapy and Bisphosphonate Drug Holidays;Adler;Endocrinol. Metab. Clin. N. Am.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3